Christopher Naftzger

Christopher Naftzger re-joined Nabriva Therapeutics in September 2021. He has more than 25 years of legal experience, including over a decade of experience serving in senior in-house counsel positions with life science companies. He most recently served as General Counsel and Corporate Secretary of Krystal Biotech (NASDAQ: KRYS), an emerging-stage, gene therapy company. Before joining Krystal, he was Vice President, Deputy General Counsel and Assistant Secretary of Nabriva Therapeutics. Prior to Nabriva, Mr. Naftzger served as Vice President, General Counsel, Chief Compliance Officer, and Secretary of Unilife Medical Solutions, a developer and manufacturer of innovative drug delivery systems. Mr. Naftzger also held senior in-house counsel positions with Chesapeake Corporation and Koch Industries, and was a corporate partner with Blank Rome LLP in Washington, DC. Mr. Naftzger obtained his undergraduate degree from Hampden-Sydney College and his law degree from the Willamette University College of Law.